These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29242042)

  • 1. Neoadjuvant chemotherapy in breast cancer: more than just downsizing.
    Derks MGM; van de Velde CJH
    Lancet Oncol; 2018 Jan; 19(1):2-3. PubMed ID: 29242042
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy for operable breast cancer: individualizing locoregional and systemic therapy.
    Bear HD
    Surg Oncol Clin N Am; 2010 Jul; 19(3):607-26. PubMed ID: 20620930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for early breast cancer.
    Charalampoudis P; Karakatsanis A
    Lancet Oncol; 2018 Mar; 19(3):e128. PubMed ID: 29508753
    [No Abstract]   [Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy for early breast cancer.
    Krug D; Loibl S
    Lancet Oncol; 2018 Mar; 19(3):e129. PubMed ID: 29508754
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy for operable breast cancer.
    Green M; Hortobagyi GN
    Oncology (Williston Park); 2002 Jul; 16(7):871-84, 889; discussion 889-90, 892-4, 897-8. PubMed ID: 12164555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on 'Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques'.
    Kuerer HM; Yang WT; Krishnamurthy S
    Br J Cancer; 2016 May; 114(10):e3. PubMed ID: 27092783
    [No Abstract]   [Full Text] [Related]  

  • 7. [Option of the surgical mode for breast cancer based on the effect of neoadjuvant chemotherapy].
    Fukutomi T
    Nihon Geka Gakkai Zasshi; 2002 Nov; 103(11):803-5. PubMed ID: 12478855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply to Comment on 'Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques'.
    Heil J
    Br J Cancer; 2016 May; 114(10):e4. PubMed ID: 27092782
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose adjustment in obese breast cancer patients receiving neoadjuvant chemotherapy might have an impact on survival.
    Altundag K
    Breast Cancer Res Treat; 2018 Feb; 167(3):821. PubMed ID: 29063310
    [No Abstract]   [Full Text] [Related]  

  • 10. The hormonal receptor status in breast cancer can be altered by neoadjuvant chemotherapy: a meta-analysis.
    Zhang N; Moran MS; Huo Q; Haffty BG; Yang Q
    Cancer Invest; 2011 Nov; 29(9):594-8. PubMed ID: 22011281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant systemic chemotherapy for patients with operable breast cancer].
    Zhang B; Zhang Q
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):161-5. PubMed ID: 17649628
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy for Triple-Negative Breast Cancer: Is More Better?
    Mayer EL; Burstein HJ
    J Clin Oncol; 2016 Oct; 34(28):3369-71. PubMed ID: 27551109
    [No Abstract]   [Full Text] [Related]  

  • 13. Node micrometastases detection after neoadjuvant chemotherapy in breast cancer: is it of clinical value?
    Ziogas D; Harissis H; Batsis C
    Ann Surg Oncol; 2010 Mar; 17(3):933-4; author reply 935. PubMed ID: 19830493
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy in the treatment of breast cancer.
    Redden MH; Fuhrman GM
    Surg Clin North Am; 2013 Apr; 93(2):493-9. PubMed ID: 23464698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.
    Gianni L; Eiermann W; Semiglazov V; Manikhas A; Lluch A; Tjulandin S; Zambetti M; Vazquez F; Byakhow M; Lichinitser M; Climent MA; Ciruelos E; Ojeda B; Mansutti M; Bozhok A; Baronio R; Feyereislova A; Barton C; Valagussa P; Baselga J
    Lancet; 2010 Jan; 375(9712):377-84. PubMed ID: 20113825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
    Kim R; Osaki A; Tanabe K; Toge T
    Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future role of neoadjuvant therapy for breast cancer.
    Untch M; Konecny GE; Paepke S; von Minckwitz G
    Breast; 2014 Oct; 23(5):526-37. PubMed ID: 25034931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Taxanes in neojuvant radio-, chemoradio- and chemotherapy for breast cancer].
    Bozhok AA; Semiglazov VF; Kletzel' AE; Arzumanov AS; Mel'nikova OA; Paltuev RM; Ivanova OA; Semiglazov VV
    Vopr Onkol; 2006; 52(1):7-14. PubMed ID: 16715697
    [No Abstract]   [Full Text] [Related]  

  • 20. [Not Available].
    Gonçalves A
    Bull Cancer; 2016 Jun; 103(6 Suppl 1):S76-89. PubMed ID: 27494978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.